PPD has expanded its global central lab services into China through an exclusive agreement with Peking Union Lawke Biomedical Development Limited.
The agreement allows PPD to begin immediately providing biopharmaceutical clients with its full range of highly customized central lab services in China.
"Chinese law makes it extremely difficult to export lab samples to other countries for testing," said Agostino L. Fede, Ph.D., senior vice president of PPD and head of PPD's global central labs. "Our agreement with PUL expands our global central lab capabilities in a high growth clinical research market. It also saves our clients time and money by providing lab results more quickly without incurring expenses for exporting shipments."
Under the terms of the agreement, PPD invested in laboratory equipment located at Peking Union Medical College in the Beijing Zhongguancun Life Sciences Park, the largest life sciences park in China.
